What is NDC 28955-107?

28955-107 is the product NDC for enoxaparin sodium, Enoxaparin sodium 150 mg/mL injection, listed with the FDA by Hebei Changshan Biochemical Pharmaceutical Co., Ltd.. It has 1 package NDC, shown above in 10- and 11-digit form.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd., NDC labeler code 28955. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for enoxaparin sodium?

140 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

enoxaparin sodium NDC 28955-107 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)28955-107Labeler and product segments. Claims need a package NDC.

Product NDC at billing width28955-0107Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
28955-107-10	2895501071028955010710	10 SYRINGE in 1 CARTON (28955-107-10) / 1 mL in 1 SYRINGEMarketed from May 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): enoxaparin sodium
Generic name (nonproprietary): enoxaparin sodium
Active ingredients: Enoxaparin sodium — 150 mg/mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Hebei Changshan Biochemical Pharmaceutical Co., Ltd.NDC labeler code 28955
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218775
Marketing start: May 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Low-Molecular-Weight (Chemical structure)
Identifiers: Product ID 28955-107_486592e2-4eef-525e-e063-6394a90a3048SPL ID 486592e2-4eef-525e-e063-6394a90a3048SPL set ID 7fa78f8d-92d9-434a-8e26-b886ab0ae77fRxCUI 854228, 854235, 854238, 854241, 854245, 854248, 854252UNII 8NZ41MIK1OUPC 0328955103103, 0328955106104, 0328955105107, 0328955102106, 0328955101109, 0328955107101, 0328955104100
Pharmacologic class: Low Molecular Weight Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N428955010710 followed by a unit qualifier and the quantity

Package 28955-0107-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 14, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Enoxaparin sodium injection is a low molecular weight heparin (LMWH) indicated for: • Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1.1 ) • Inpatient treatment of acute DVT with or without pulmonary embolism (1.2) • Outpatient treatment of acute DVT without pulmonary embolism (1.2) • Prophylaxis of ischemic complications of unstable angina and non–Q-wave myocardial infarction (MI) (1.3) • Treatment of acute ST-segment elevation myocardial infarction (STEMI) managed medically or with subsequent percutaneous coronary intervention (PCI) (1.4) 1.1 Prop…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 28955-107

What is NDC 28955-107?: 28955-107 is the product NDC for enoxaparin sodium, Enoxaparin sodium 150 mg/mL injection, listed with the FDA by Hebei Changshan Biochemical Pharmaceutical Co., Ltd.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: enoxaparin sodium.
What is the active ingredient?: Enoxaparin sodium.
Who is the labeler?: Hebei Changshan Biochemical Pharmaceutical Co., Ltd., NDC labeler code 28955. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for enoxaparin sodium?: 140 other product NDCs are listed under this name. See all enoxaparin sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other enoxaparin sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
enoxaparin sodium	Enoxaparin sodium 80 mg/.8mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-104	28955-0104-10
enoxaparin sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-105	28955-0105-10
enoxaparin sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-106	28955-0106-10
enoxaparin sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-103	28955-0103-10
enoxaparin sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-101	28955-0101-10
enoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-102	28955-0102-10
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Civica, Inc.	72572-280	72572-0280-10
Enoxaparin Sodium	Enoxaparin sodium 300 mg/3mL	InjectionIntravenous, Subcutaneous	BluePoint Laboratories	68001-641	68001-0641-41
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	BluePoint Laboratories	68001-633	68001-0633-42
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	BluePoint Laboratories	68001-635	68001-0635-42

All 141 enoxaparin sodium NDCs

Other NDCs under ANDA 218775

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218775
Product	Strength	Form · route	Labeler	Product NDC
enoxaparin sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-101
enoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-102
enoxaparin sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-103
enoxaparin sodium	Enoxaparin sodium 80 mg/.8mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-104
enoxaparin sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-105
enoxaparin sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-106